KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio: 2009-2025

Historic Interest Coverage Ratio for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to -18.10.

  • Biomarin Pharmaceutical's Interest Coverage Ratio fell 147.18% to -18.10 in Q3 2025 from the same period last year, while for Sep 2025 it was 57.53, marking a year-over-year increase of 166.02%. This contributed to the annual value of 38.23 for FY2024, which is 256.73% up from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Interest Coverage Ratio is -18.10, which was down 117.52% from 103.35 recorded in Q2 2025.
  • Biomarin Pharmaceutical's 5-year Interest Coverage Ratio high stood at 103.35 for Q2 2025, and its period low was -18.10 during Q3 2025.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 24.94 (2024), whereas its average is 33.63.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Interest Coverage Ratio soared by 1,663.71% in 2023 and then tumbled by 147.18% in 2025.
  • Biomarin Pharmaceutical's Interest Coverage Ratio (Quarterly) stood at -17.13 in 2021, then surged by 78.93% to -3.61 in 2022, then surged by 223.94% to 4.47 in 2023, then skyrocketed by 1,300.13% to 62.63 in 2024, then slumped by 147.18% to -18.10 in 2025.
  • Its Interest Coverage Ratio was -18.10 in Q3 2025, compared to 103.35 in Q2 2025 and 78.20 in Q1 2025.